During skeletal development, osteoblasts produce large amounts of extracellular matrix proteins and must therefore increase their secretory machinery to handle the deposition. The accumulation of unfolded protein in the endoplasmic reticulum induces an adoptive mechanism called the unfolded protein response (UPR). We show that one of the most crucial UPR mediators, inositolrequiring protein 1a (IRE1a), and its target transcription factor X-box binding protein 1 (XBP1), are essential for bone morphogenic protein 2-induced osteoblast differentiation. Furthermore, we identify Osterix (Osx, a transcription factor that is indispensible for bone formation) as a target gene of XBP1. The promoter region of the Osx gene encodes two potential binding motifs for XBP1, and we show that XBP1 binds to these regions. Thus, the IRE1a-XBP1 pathway is involved in osteoblast differentiation through promoting Osx transcription.
INTRODUCTION
To manage the burden of protein synthesis, cells augment the folding and secretory capacity of the endoplasmic reticulum (ER) in response to the accumulation of misfolded proteins. This system, known as the unfolded protein response (UPR), is a highly conserved cellular mechanism in eukaryotic cells. In mammalian cells, there are three classes of ER stress transducers involved in the UPR including inositol-requiring protein 1a (IRE1a), activating transcription factor 6 (ATF6) and pancreatic ER kinase (PERK), and their functions in the UPR have been a subject of intensive study in the past decade (Rutkowski & Kaufman, 2004; Xu et al, 2005; Ron & Walter, 2007; Hetz & Glimcher, 2009) .
The activation of the UPR is especially important in cells specialized to secrete proteins including plasma cells, endocrine cells and osteoblasts. Past studies have shown that PERK and OASIS (old astrocyte specifically induced substance), an ATF6 homologue (Murakami et al, 2009) , are involved in skeletal development. However, a potential role for IRE1a in osteoblast differentiation remains uninvestigated. IRE1a is a type-1 transmembrane protein harbouring both a kinase domain and an endoribonuclease domain. The former is involved in the recruitment of tumour necrosis factor receptor-associated factor 2 (TRAF2)-which in turn activates JUN amino-terminal kinase (JNK)-and the latter is involved in the processing of X-box binding protein 1 (XBP1) mRNA. The consequences of JNK activation through IRE1a signalling are not fully understood; however, it is probably involved in the initiation of autophagy (Ogata et al, 2006) and in the promotion of apoptosis (Yoneda et al, 2001 ). XBP1 derived from spliced Xbp1 mRNA (XBP1s) translocates to the nucleus and binds to UPR elements to induce the transcription of a variety of UPR genes that mainly function to alleviate ER stress (Yoshida et al, 2001; Acosta-Alvear et al, 2007) . Mice lacking IRE1a or XBP1 were embryonically lethal and died at around 9.5-11.5 or 11.5-14.5 days post-coitum (dpc), respectively, supporting the idea that these genes are important in vivo (Reimold et al, 2000; Urano et al, 2000) .
We investigated the potential role of IRE1a in osteoblast differentiation and found that the IRE1a-XBP1 pathway is essential for bone morphogenic protein 2 (BMP2)-induced osteoblast differentiation. Moreover, we identified Osterix (Osx)-one of the essential transcription factors for osteoblast differentiation (Nakashima et al, 2002) -as a target gene for XBP1s. In addition, we found that thapsigargin, a potent inducer of ER stress, can promote Osx transcription in BMP2-treated fibroblasts and in an osteoblast cell line-MC3T3-E1-in an IRE1a-XBP1-dependent manner. Taken together, these observations show a previously unknown relationship between the IRE1a-XBP1 pathway and Osx, and might provide new insights into the mechanisms underlying UPR and skeletal development.
RESULTS AND DISCUSSION
To examine the possible involvement of IRE1a signalling in osteoblast-differentiation, we performed in vitro osteoblastdifferentiation experiments using mouse embryonic fibroblasts (MEFs) and recombinant BMP2, which is known to stimulate osteogenic differentiation processes in undifferentiated fibroblasts in vitro. The expression levels of two transcription factors that are essential for osteoblast differentiation, Runx2 and Osx (Komori et al, 1997; Nakashima et al, 2002) , and the bone extracellular matrix proteins COL1A1 and osteocalcin (OCN; markers for early and late stages of osteoblast differentiation, respectively), were evaluated to monitor the degree of differentiation. The expression levels of these osteoblastic markers in the MEFswhich were almost undetectable when cultured in maintenance medium-were significantly increased by the addition of BMP2 (Fig 1A) . By contrast, the expression level of IRE1a showed no change during the course of the experiment (Fig 1B) . However, we found that mRNA expression levels of total Xbp1 (including both unspliced (Xbp1u) and spliced Xbp1 (Xbp1s) mRNA), Xbp1s and BiP/GRP78 chaperone were significantly upregulated, indicating that the UPR was induced by BMP2 in MEFs, probably to deal with the increase in protein synthesis that is known to occur in these conditions. There was also an increase in the expression (-) (H) Quantitative PCR analysis of osteoblast markers showed no difference between control (Ctrl) and Traf2-siRNA-treated wild-type MEFs incubated with BMP2. The expression level of each gene in the control siRNA-transfected MEFs was set to one. *Po0.05. ALP, alkaline phosphatase; BMP2, bone morphogenic protein 2; Ctrl, control; IRE1a, inositol-requiring protein 1a; MEF, mouse embryonic fibroblast; NS, not significant; Ocn, Osteocalcin; Osx, Osterix; RT, reverse transcription; siRNA, small-interfering RNA; TRAF, tumour necrosis factor receptor-associated factor 2; UPR, unfolded protein response; XBP1, X-box binding protein 1.
IRE1a signalling promotes Osterix transcription T. Tohmonda et al mice (Iwawaki et al, 2004) , in which fluorescent protein is induced on activation of IRE1a. As shown in Fig 1D, there was a significant increase in fluorescence activity in the BMP2-treated calvarial bone collected from newborn ERAI-transgenic mice, especially in the junction of the sagittal and coronal sutures, where bone formation is achieved through direct differentiation of mesenchymal cells to osteoblasts. This observation illustrates that Xbp1 transcripts are processed in the activated osteoblasts. Next, we used MEFs lacking IRE1a to investigate how the absence of IRE1a in MEFs would affect their osteoblast-differentiation capacity and the production of extracellular matrix proteins. As shown in Fig 2A, the addition of BMP2 significantly increased alkaline phosphatase (ALP) activity in wild-type MEFs, compared with minimal or no increase in Ire1a À/À MEFs. These results indicate that BMP2-induced osteoblast differentiation is hampered by the absence of IRE1a. The absence of Xbp1s mRNA expression in Ire1a À/À MEFs was confirmed by reverse transcription (RT)-PCR (Fig 2B) . A time course expression analysis of the aforementioned osteoblast markers by quantitative RT-PCR in BMP2-treated MEFs showed reduced expression in Ire1a À/À MEFs, compared with control MEFs (Fig 2C) . The expression levels of other osteoblast markers-including bone sialoprotein, osteopontin and osteonectin-were also significantly reduced in Ire1a À/À MEFs, compared with control MEFs (supplementary Fig S2 online) . As it is also conceivable that the hampered osteoblast differentiation in Ire1a À/À MEFs was derived from an increase in apoptosis, we evaluated the apoptosis in BMP2-treated Ire1a À/À and wildtype MEFs. As expected, there was an increase in the apoptosis rate in Ire1a À/À MEFs compared with wild-type MEFs; however, the overall ratio of the apoptotic cell rate was low (1.7% and 3.5% in wild-type and Ire1a À/À MEFs, respectively), suggesting that the increased apoptosis in the absence of IRE1a was not the primary cause for the defect in differentiation (supplementary Fig S3 online) . Notably, even in the absence of IRE1a, there was a transient increase (peaking at around 48 h) in the expression levels of Runx2 and Col1a1 after BMP2 treatment, whereas the expression levels of Osx and Ocn (late-stage markers of osteoblast differentiation) remained almost unchanged. Taken Chromatin immunoprecipitation assays using a control rabbit IgG, XBP1 antibody or RUNX2 antibody (RX2, used as a negative control; lower panels). A set of primers that amplifies the region outside the putative binding sites was used as a negative control for the experiment. IgG, immunoglobulin G; IP, immunoprecipitation; mEF, mouse embryonic fibroblast; NS, not significant; Ocn, Osteocalcin; Osx, Osterix; POB, primary osteoblasts; UPR, unfolded protein response; XBP1, X-box binding protein 1; XBP1s, spliced X-box binding protein 1; XBP1u, unspliced X-box binding protein 1.
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together, these observations indicate that the maturation of osteoblasts is inhibited in the absence of IRE1a, whereas the initial stage of differentiation-in which undifferentiated mesenchymal cells commit to the osteoblast lineage-is not affected. It has been shown previously that IRE1a not only processes Xbp1 mRNA, but can also activate stress-induced JNK through recruitment of TRAF2 (Urano et al, 2000) . Next, we asked which of these pathways is more involved in BMP2-induced osteoblast differentiation. We used small interfering RNA (siRNA)-mediated gene silencing to suppress the expression of XBP1 and TRAF2 in wild-type MEFs and subjected these cells to in vitro osteoblastdifferentiation experiments. In Ire1a-and Xbp1-siRNA-transfected MEFs, the increase in ALP activity after BMP2 treatment was reduced to a level comparable to that observed in Ire1a À/À MEFs (Fig 2D) . The reduction in the amount of Xbp1s mRNA was confirmed by quantitative RT-PCR (Fig 2E) . In addition, we found that the mRNA expression levels of Col1a1 and Osx were significantly reduced, whereas that of Runx2 remained unaltered (Fig 2F) . Conversely, introduction of Traf2-siRNA into MEFs had little effect on their potential to induce ALP after BMP2 treatment (Fig 2G, left panel) . The suppression of the transcript level of Traf2 in siRNA-transfected MEFs was confirmed by quantitative RT-PCR (Fig 2G, right panel) . Consistently, there was no change in mRNA expression levels in any of the osteoblast markers in Traf2-siRNAtreated cells (Fig 2H) . Taken together, these observations suggest that the IRE1a-XBP1, but not the IRE1a-TRAF2, pathway is essential for BMP2-induced osteoblast differentiation.
To gain insight into the regulatory mechanism underlying IRE1a-XBP1 and osteoblast differentiation, we performed a reporter assay using reporter constructs carrying the promoter of Runx2, Osx, Col1a1 and Ocn. Unexpectedly, we found that reporter activity was highly induced in cells transfected with an Osx-reporter vector and XBP1s expression vector, and to a lesser extent in the cells transfected with a Col1a1-reporter vector (Fig 3A) . By contrast, there was no change in reporter activity in the cells transfected with a Runx2-or Ocn-reporter vector. Introduction of the unspliced version of XBP1-which could potentially interfere with the activity of XBP1s (Yoshida et al, 2006) -had no effect on reporter activity in the cells transfected with any of the four reporter constructs. In addition, co-transfection of ATF4 (which functions downstream of PERK) or ATF6 expression vector with the Osx-reporter construct did not show any change Yoshida et al, 2001 ) and an XBP1-binding sequence (ACGT; Acosta-Alvear et al, 2007), which are highly conserved among species (Fig 3B) . On the basis of these sequence data, we generated several mutant reporter constructs and performed a luciferase assay. As shown in Fig 3C , the shorter reporter constructs-which lack one (Osx À786) or both (Osx À355) of the aforementioned putative binding motifs-showed a decrease in luciferase activity, compared with the full-length construct (Osx À1269). Furthermore, the mutant constructs-which lack either one (Osx 1269 D504-491 and Osx À1269 DÀ830-821) or both (Osx À1269 DÀ830-821, 504-491) binding motifs-also showed a significant decrease in the XBP1s-driven luciferase activity. Chromatin immunoprecipitation assays confirmed that XBP1 binds to the promoter region of Osx containing either one of the putative binding motifs in MEFs, MC3T3-E1 cells and primary osteoblasts from wild-type newborn mice (Fig 3D) .
The observations that XBP1s promotes Osx transcription in the reporter assay led us to ask whether ER stress alone is capable of inducing Osx transcription. We repeated the reporter assays using the aforementioned Osx reporter constructs and found that ER stress induced by thapsigargin is able to promote Osx reporter activity (supplementary Fig S4 online) . Furthermore, this activity was abolished in Ire1a À/À MEFs, in which no Xbp1s mRNA is expressed (Fig 2B) , indicating that ER stress-induced Osx reporter activity is dependent on IRE1a, presumably involving IRE1a-mediated induction of XBP1s. Next, we incubated wild-type and Ire1a À/À MEFs with thapsigargin for 3 or 6 h and then examined the transcript level of Osx by quantitative RT-PCR. As shown in Fig 4A, there was no change in Osx transcripts in either wild-type or Ire1a À/À MEFs; however, when the cells were preincubated with BMP2 for 16 h, the addition of thapsigargin significantly induced the Osx transcripts in wild-type, but not in Ire1a À/À , MEFs. Furthermore, we found that treatment with thapsigargin alone was sufficient to promote Osx transcripts in a preosteoblastic cell-line, MC3T3-E1 (Fig 4B) . The thapsigargin-induced Osx transcripts were abolished by gene silencing of Xbp1 (Fig 4C) , indicating that upregulation of Osx transcripts by thapsigargin is XBP1s-dependent. Consistently, overexpression of XBP1s was also capable of inducing Osx transcripts, but not those of Runx2, in MC3T3-E1 cells (Fig 4D) . These observations suggest that after a cell differentiates into a preosteoblast, Osx becomes inducible by XBP1-dependent UPR signalling.
Finally, to consolidate our observations, we examined whether the introduction of Osx to Ire1a À/À MEFs could rescue the defect in BMP2-induced osteoblastic differentiation. As shown in Fig 4E, we found that enhanced expression of Osx can partly restore ALP activity in the BMP-treated Ire1a À/À MEFs, further supporting a functional link between the IRE1a-XBP1 pathway and Osx.
In summary, this study indicates that UPR has two functions during osteoblast differentiation: (i) to expand the capacity of the ER to cope with the increase in the production of extracellular matrix proteins, and to avoid the cells producing matrix proteins from apoptosis induced by ER overload (Hino et al, 2010) ; (ii) to stimulate Osx expression through the IRE1a-XBP1 pathway to promote the maturation of preosteoblasts into osteoblasts (Fig 4F) . In comparison to Runx2, the functions and the molecular regulation of Osx are poorly understood, although both genes are equally indispensible for skeletogenesis (Komori, 2006; Karsenty, 2008) . Therefore, the unexpected link between the IRE1a-XBP1 pathway and Osx identified here might shed new light on the understanding of the UPR and osteoblast differentiation.
METHODS
Cells and reagents. The generation of Ire1a À/À and wild-type MEFs was described previously (Urano et al, 2000) . Primary osteoblasts were collected from the calvaria from 18.5 dpc wild-type embryos. Recombinant human BMP2 was purchased from Wako (Osaka, Japan). IRE1a antibody (14C10), XBP1 antibody (M-186), RUNX2 antibody (M-70) and actin antisera were from Cell Signaling, Santa Cruz (M-186 and M-70) and Sigma-Aldrich, respectively. Ire1a, Xbp1, Traf2 and non-targeting control siRNA were purchased from Sigma Genosys. Luciferase assay. Luciferase assay was performed using a dual luciferase assay system (Promega). pRL-SV40 (Promega) was used as a transfection efficiency control. The assays were performed 16 h after the transfection of reporter constructs and expression vectors. Transcriptional activity was expressed as a ratio of firefly:Renilla luciferase activity. Chromatin immunoprecipitation assay. MC3T3-E1 cells, MEFs and primary osteoblasts were cultured in BMP2-supplemented medium for 72 h. The cells were fixed by 1% paraformaldehyde/ phosphate-buffered saline for 10 min at 23 1 C. Chromatin shearing and immunoprecipitation were performed using ChIP-IT Express Chromatin Immunoprecipitation Kits (Active Motif), as instructed by the manufacturer. The isolated DNA fragments were used as templates for PCR amplification (see Fig 3D for a schema showing the target region for PCR and supplementary Table S1 online for the PCR primers used in this study). Statistical analysis. A student's t-test for two samples assuming equal variances was used to calculate P-values. P-values o0.05 were considered statistically significant. All experiments, including the reporter assay, quantitative RT-PCR and chromatin immunoprecipitation assay, were repeated at least three times. Error bars indicate standard deviation.
Detailed description of the constructs and the protocols for immunostaining, evaluation for ALP activity, ex vivo culture of calvariae and quantitative RT-PCR are provided in the supplementary information online. Supplementary information is available at EMBO reports online (http://www.emboreports.org).
